RENERVE PLUS

This brand name is authorized in Nigeria.

Active ingredients

The drug RENERVE PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII BR1SN1JS2W - METHYLCOBALAMIN
 

Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years.

 
Read more about Vitamin B12
2
UNII 73Y7P0K73Y - ALPHA LIPOIC ACID
 
Read more about Thioctic acid
3
UNII 4L6452S749 - INOSITOL
 
Read more about Inositol
4
UNII 935E97BOY8 - FOLIC ACID
 

Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues.

 
Read more about Folic acid
5
Chromium polynicotinate
UNII A150AY412V - CHROMIUM NICOTINATE
6
Selenomethionine
UNII 964MRK2PEL - SELENOMETHIONINE
7
UNII ZIO23CX10K - ZINC METHIONINE SULFATE
 

Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells.

 
Read more about Zinc

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A11JB Vitamins with minerals A Alimentary tract and metabolism → A11 Vitamins → A11J Other vitamin products, combinations
Discover more medicines within A11JB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-8632
Switch country to Nigeria in order to find specific presentations of RENERVE PLUS

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.